- Home
- BBLG vs AEMD Comparison
BBLG vs AEMD Comparison
Compare BBLG & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BBLG | AEMD |
|---|---|---|
| Founded | 2004 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BBLG | AEMD |
|---|---|---|
| Price | $1.74 | $2.76 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $287.50 |
| AVG Volume (30 Days) | ★ 878.7K | 55.0K |
| Earning Date | 02-27-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.30 | $2.22 |
| 52 Week High | $7.74 | $64.00 |
Technical Indicators
Market Signals| Indicator | BBLG | AEMD |
|---|---|---|
| Relative Strength Index (RSI) | 51.12 | 49.15 |
| Support Level | $1.58 | $2.59 |
| Resistance Level | $1.88 | $3.19 |
| Average True Range (ATR) | 0.11 | 0.30 |
| MACD | 0.02 | 0.07 |
| Stochastic Oscillator | 66.00 | 64.39 |
Price Performance
Historical ComparisonAbout BBLG Bone Biologics Corp
Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.
About AEMD Aethlon Medical Inc.
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.